Understanding a patient’s unique response to antiplatelet medications is essential to effective treatment decisions. The VerifyNow system offers platelet reactivity results in minutes, providing antiplatelet therapy guidance in many clinical settings, including the Operating Room, Cardiac Catheterization Lab, Interventional Radiology, as well as in the Lab. The most cited and utilized platelet reactivity testing system, VerifyNow is an indispensable aid to optimizing patient outcomes.
Antiplatelet therapy response assessment.
Guides patient management throughout the hospital
The VerifyNow System provides an easy, rapid, and proven solution to assess platelet reactivity to antiplatelet medications, such as Aspirin and clopidogrel. Testing can measure the effect of antiplatelet therapy prior to discharge, ensure patient drug response to generic medications, identify patients at risk for an antiplatelet-related bleeding or major adverse cardiac event and identify therapeutic non-compliance. This may help reduce time off antiplatelet therapy, standard pre-op blood platelet orders, length of stay prior to surgery, and 30-day admissions.
- Optimizes patient outcomesVerifyNow Aspirin Test measures a patient's platelet response to Aspirin, while VerifyNow PRUTest* helps identify patients responsive to antiplatelet therapy. VerifyNow testing can measure antiplatelet effect prior to discharge, ensure drug response, identify risk for a related bleeding, thrombotic or major cardiac event, as well as non-compliance.
- AccurateThe system uses Light-Transmission Aggregometry (LTA), requiring no manipulation, eliminating analytical sample variation. Gold standard technology for pharmaceutical development.
- Simple integrationEasy to use, no pipetting or sample preparation, reducing the risk of pre-analytical error. Sample-to-answer results in a fully contained, single-use test system, makes the VerifyNow system ideal for point-of-care testing, as well as in the lab.
VerifyNow Aspirin Test
Aids in assessing how Aspirin is affecting platelets, allowing rapid, informed treatment decisions.
Measures the level of platelet P2Y12-receptor blockade to help identify patient response to antiplatelet therapy, including clopidogrel (Plavix), prasugrel (Effient) and ticagrelor (Brilinta).
*Not available in all countries.